<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85092</article-id><article-id pub-id-type="doi">10.7554/eLife.85092</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-299764"><name><surname>Warren</surname><given-names>Rachel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9438-2975</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-299829"><name><surname>Lyu</surname><given-names>Handeng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-299767"><name><surname>Klinkhammer</surname><given-names>Kylie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-80717"><name><surname>De Langhe</surname><given-names>Stijn PJ</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3867-4572</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Medicine</institution>, <institution>Mayo Clinic</institution>, <addr-line><named-content content-type="city">Rochester</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-109584"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing editor</role><aff><institution>Cedars-Sinai Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>delanghe.stijn@mayo.edu</email> (SD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>05</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e85092</elocation-id><history><date date-type="received"><day>21</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>10</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Warren et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Warren et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85092-v1.pdf"/><abstract><p>Idiopathic pulmonary fibrosis (IPF) consists of fibrotic alveolar remodeling and progressive loss of pulmonary function. Genetic and experimental evidence indicate that chronic alveolar injury and failure to properly repair the respiratory epithelium are intrinsic to IPF pathogenesis. Loss of alveolar type 2 (AT2) stem cells or mutations that either impair their self-renewal and/or impair their differentiation into AT1 cells can serve as a trigger of pulmonary fibrosis. Recent reports indicate increased YAP activity in respiratory epithelial cells in IPF lungs. Individual IPF epithelial cells with aberrant YAP activation in bronchiolized regions frequently co-express AT1, AT2, conducting airway selective markers and even mesenchymal or EMT markers, demonstrating 'indeterminate' states of differentiation and suggesting that aberrant YAP signaling might promote pulmonary fibrosis. Yet, Yap and Taz have recently also been shown to be important for AT1 cell maintenance and alveolar epithelial regeneration after <italic>Streptococcus pneumoniae</italic> induced injury.  To investigate how epithelial Yap/Taz might promote pulmonary fibrosis or drive alveolar epithelial regeneration, we inactivated the Hippo pathway in AT2 stem cells resulting in increased nuclear Yap/Taz and found that this promotes their alveolar regenerative capacity and reduces pulmonary fibrosis following bleomycin injury by pushing them along the AT1 cell lineage. Vice versa, inactivation of both <italic>Yap1</italic> and <italic>Wwtr1</italic> (encoding Taz) or <italic>Wwtr1</italic> alone in AT2 cells stem cells impaired alveolar epithelial regeneration and resulted in increased pulmonary fibrosis upon bleomycin injury. Interestingly, inactivation of only <italic>Yap1</italic> in AT2 stem cells promoted alveolar epithelial regeneration and reduced pulmonary fibrosis. Together, these data suggest that epithelial Yap promotes, and epithelial Taz reduces pulmonary fibrosis suggesting that targeting Yap but not Taz mediated transcription might help promote AT1 cell regeneration and treat pulmonary fibrosis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R35 HL161169</award-id><principal-award-recipient><name><surname>De Langhe</surname><given-names>Stijn PJ</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01 HL146461</award-id><principal-award-recipient><name><surname>De Langhe</surname><given-names>Stijn PJ</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01 HL132156</award-id><principal-award-recipient><name><surname>De Langhe</surname><given-names>Stijn PJ</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>T32 HL105355</award-id><principal-award-recipient><name><surname>Warren</surname><given-names>Rachel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#A00006342-21) of the Mayo clinic.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>sequencing data have been uploaded to Dryad</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Warren R</collab><collab>Lyu H</collab><collab>Gao S</collab><collab>Klinkhammer K</collab><collab>De Langhe SP</collab></person-group><year iso-8601-date="2022">2022</year><source>Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis</source><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.5061/dryad.tdz08kq3d">https://dx.doi.org/10.5061/dryad.tdz08kq3d</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.tdz08kq3d</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-85092-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>